Why Is HIMS & HERS HEALTH I A (HIMS) Stock Up Today?

Why HIMS stock is up today

HIMS stock surged 10.98% to $30.82 on Friday, driven by a combination of short-term investor speculation and regulatory developments. The stock has faced significant bearish pressure in recent months, with heavy short interest and a 52-week low of $13.74. However, unusual options activity and a potential earnings report on August 10 have created a catalyst for a sharp intraday reversal.

What Happened

Kaplan Fox Kilsheimer LLP announced a securities investigation into Hims & Hers Health, prompting investor scrutiny and potentially signaling a shift in market perception. This development came alongside a report that the FTC may be suing the company for sharing user health data with advertisers, though Hims & Hers has denied the allegations and expressed confidence in its legal position. Meanwhile, unusual options activity over the last 36 hours included $7.6 million in call premiums and $297,000 in put premiums, with the largest single trade valued at $6.3 million. These factors, combined with a 14% projected price swing ahead of the August 10 earnings report, have drawn attention to the stock.

What The Data Shows

Over the last eight sessions, HIMS had fallen 14.4% from $32.29 to $27.65, reflecting a broader trend of declining investor sentiment. The stock's fundamentals remain weak, with a trailing 12-month revenue increase of 32.8% but an unprofitable EPS of -0.06 and a net margin of -0.6%. Short interest remains high, with the stock among the most shorted in the healthcare sector as of late July. Insider transactions also show a net outflow, with the CFO selling shares on three separate occasions in June and July.

What To Watch

Investors should closely monitor the company's earnings report on August 10, which may provide clarity on its financial health and future outlook. Coverage breadth and sentiment shifts in the coming days will also be key indicators of the stock's trajectory.